Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,504.9
20.0 (0.80%)

 

  • STI Straits Times Index
    2,504.9
    20.0 (0.80%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.3
    1.7 (0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,672.5
    214.4 (0.88%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,365.8
    -2.2 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,512.2
    316.8 (1.43%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,034.5
    28.3 (0.56%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 401.0M
  • Value: 392.7M
  • Rise: 114
  • Fall: 93
  • Unch: 601

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Citicode0.001-
Medtecs Intl0.990-0.020
Singapore-eDev0.094+0.005
Moya Asia0.072-
Singtel2.390-0.060
AEM4.000+0.340
Silverlake Axis0.305+0.010
Trendlines0.108+0.003
IPS Securex0.126+0.001
Rex Intl0.183+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MORPHIC HOLDING INC MORPHIC HOLDING INC
Updated on 03 Aug 2020 (End of trading day)
Last (USD): 23.600 Change: +1.090 High: 23.910 Remarks: -
Change (%): +4.84 Low: 22.765
Open 22.800 Yesterday's Close 22.51
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 24,268 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.41377 Trailing EPS (USD) e -1.41377 NAV (USD) b 4.1810
PE a - Trailing PE f - Price / NAV b 5.6446
Dividend (USD) d - Cash In Hand (USD) g 3.4925 Issued & Paid-up Shares c 30,647,100
Dividend Yield (%) d - Price / Cash In Hand g 6.757 Treasury Shares h -
Market Cap (M) 723.272 Enterprise Value (M) 504.260
Piotroski F Score 3 Exchange Code MORF Par Value ( $ ) n.a.
52 Weeks Volatility (%) 82.61 Free Float (%) 41.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 19 Jun 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MORPHIC HOLDING INC NASDAQ 723.272 - - 5.6446 -
Industry Biotechnology NASDAQ 2,874.853 436.404 6455.431 9.1119 0.656
Local Peer AMGEN INC NASDAQ 144,877.268 18.475 19.849 13.5920 2.368
Local Peer GILEAD SCIENCES INC NASDAQ 89,975.960 16.706 29.194 - 3.546
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 72,596.925 34.312 31.851 5.9834 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 72,473.107 61.584 58.281 - -
Local Peer ILLUMINA INC NASDAQ 58,485.420 58.369 62.086 12.6182 -
Local Peer BIOGEN INC NASDAQ 44,036.344 7.478 7.430 3.8940 -
Local Peer SEATTLE GENETICS INC NASDAQ 29,412.453 - - - -
Local Peer MODERNA INC NASDAQ 30,320.496 - - 18.4782 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,980.289 9.558 27.160 2.1905 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 22,069.347 - 193.581 6.8116 -
Local Peer INCYTE CORPORATION NASDAQ 22,126.398 49.510 - 11.4187 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 20,356.646 - - - -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), VAXCYTE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), EPIZYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), REGENXBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), COMPUGEN (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), PASSAGE BIO INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VAXART INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AKOUOS INC (NASDAQ), AVROBIO INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), MERUS B V (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), NEXTCURE INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CHIASMA INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), OTONOMY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VACCINEX INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARAVIVE INC (NASDAQ), RESTORBIO INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), OCUGEN INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), COHBAR INC (NASDAQ), SOLIGENIX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), PRECIPIO INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 125,839.680 46.904 43.441 14.5506 0.957
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 223,761.047 194.648 194.648 15.6470 -
Global Peer SINO BIOPHARM HKEx 188,726.000 61.489 62.052 5.4472 0.531
Global Peer BEIGENE HKEx 158,919.950 - - 7.2908 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,186.480 113.514 79.723 - -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,549.242 - - 10.5770 -
Global Peer 3SBIO HKEx 24,623.741 22.302 22.302 2.2871 -
Global Peer HAOHAI BIOTEC HKEx 18,909.278 44.976 44.976 3.2149 0.720
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), IBIO INC (NYSE American), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), IMMUTEP LTD (ASX), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), ANTEOTECH LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CT ENTERPRISE (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), REGENEUS LTD (ASX), REGENT PACIFIC (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), HAO WEN H-OLD (HKEx), HAO WEN H-NEW (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --3.420
-12.66 %
10 Days --3.020
-11.34 %
20 Days --2.190
-8.49 %
Medium Term Return 3 Months -+10.270
+77.04 %
6 Months -+3.680
+18.47 %
1 Year -+1.450
+6.55 %
Annualised Return Annualised --
+6.55 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 9.900 - 33.500 Change From 1 Year Low +13.700 % Change From 1 Year Low (%) +138.38
Change From 1 Year High -9.900 % Change From 1 Year High (%) -29.55
2 Years Range 9.900 - 33.500 Change From 2 Years Low +13.700 % Change From 2 Years Low (%) +138.38
Change From 2 Years High -9.900 % Change From 2 Years High (%) -29.55
5 Years Range 9.900 - 33.500 Change From 5 Years Low +13.700 % Change From 5 Years Low (%) +138.38
Change From 5 Years High -9.900 % Change From 5 Years High (%) -29.55
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Aug 2020 22.800 23.910 22.765 23.600 24,268 -
31 Jul 2020 24.510 25.151 22.100 22.510 91,855 -
30 Jul 2020 26.230 26.570 24.310 24.650 35,775 -
29 Jul 2020 26.030 27.440 25.895 26.750 28,808 -
28 Jul 2020 26.810 28.178 25.450 26.130 102,586 -
27 Jul 2020 24.820 27.110 24.820 27.020 43,853 -
24 Jul 2020 25.250 25.250 23.850 24.830 33,539 -
23 Jul 2020 26.640 27.795 25.020 25.440 26,832 -
22 Jul 2020 26.510 27.240 26.400 26.830 27,180 -
21 Jul 2020 26.920 27.490 26.530 26.770 58,839 -
20 Jul 2020 25.400 27.375 25.400 26.620 91,477 -
17 Jul 2020 25.370 26.410 24.970 25.370 44,945 -
16 Jul 2020 25.130 25.740 24.060 25.280 45,434 -
15 Jul 2020 25.420 26.090 24.310 25.670 50,665 -
14 Jul 2020 24.440 25.400 22.000 24.740 40,268 -
13 Jul 2020 26.090 26.090 24.400 24.490 33,969 -
10 Jul 2020 25.480 26.140 24.950 25.670 114,877 -
09 Jul 2020 25.090 26.410 24.670 25.530 59,932 -
08 Jul 2020 25.160 26.000 24.380 25.000 43,296 -
07 Jul 2020 25.560 27.070 25.230 25.310 50,497 -
06 Jul 2020 26.480 26.480 25.430 25.790 49,393 -
02 Jul 2020 26.610 26.890 25.830 25.980 62,155 -
Summary
Current 2 Weeks
(21 Jul 2020 to 03 Aug 2020)
26.920 28.178 22.100 23.600 473,535 -
Previous 2 Weeks
(07 Jul 2020 to 20 Jul 2020)
25.560 28.178 22.100 26.620 575,360 -
4 Weeks from
(08 Jun 2020 to 06 Jul 2020)
22.000 28.178 21.885 25.790 3,110,688 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.